Hugo Gonzalez Velozo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hugo Gonzalez Velozo has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Catharina Hagerling
Department of Experimental Medical Science, Lund University, Lund, Sweden
40 shared publications - Geoffroy Durand
Division of Clinical Genetics, Department of Laboratory Medicine, Lund Uni-versity, Lund, Sweden
40 shared publications - Gustav Christensson
Department of Experimental Medical Science, Lund University, Lund, Sweden
40 shared publications - Gustav Lanzing
Department of Experimental Medical Science, Lund University, Lund, Sweden
40 shared publications - Julhash Uddin Kazi
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
40 shared publications - Kristian Pietras
Lund University
40 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (9) , e3003986
Discovery Stack Pilot demonstrates the feasibility and outcomes of a scientist-designed peer-review model that separates quality and impact
Peer review serves as the cornerstone of scientific quality control. Yet, the current journal-centric system is hindered by long timelines, high publication costs, inconsistent review quality, systemic biases, and editorial gatekeeping. Notably, the system relies on misaligned measures of impact that are tethered to journal branding and conflate scientific rigor ( Quality ) with perceived significance ( Impact ). Here, we report findings from the Discovery Stack Pilot Study, which tested a scientist-designed, journal-independent peer review model. The Discovery Stack model integrates in-line reviewer comments to promote constructive feedback and separately evaluates scientific Quality and Impact using defined criteria. To examine feasibility and effectiveness, manuscripts were reviewed in parallel with traditional journal review. A total of 162 reviews were completed, and survey data from 86 participants were analyzed. The results showed that reviewers effectively evaluated Quality and Impact as separate dimensions, with Quality scores being more consistent across reviewers than Impact scores. Participants strongly supported the core elements of the Discovery Stack model and expressed enthusiasm for its broader adoption to enhance transparency, efficiency, and value in peer review. Future studies will explore integrating this model into a digital platform for reviewing and curating scientific discoveries to improve the production and dissemination of high-quality research.
- 8 September 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (9) , e3003986
Open AccessDiscovery Stack Pilot demonstrates the feasibility and outcomes of a scientist-designed peer-review model that separates quality and impact
Peer review serves as the cornerstone of scientific quality control. Yet, the current journal-centric system is hindered by long timelines, high publication costs, inconsistent review quality, systemic biases, and editorial gatekeeping. Notably, the system relies on misaligned measures of impact that are tethered to journal branding and conflate scientific rigor ( Quality ) with perceived significance ( Impact ). Here, we report findings from the Discovery Stack Pilot Study, which tested a scientist-designed, journal-independent peer review model. The Discovery Stack model integrates in-line reviewer comments to promote constructive feedback and separately evaluates scientific Quality and Impact using defined criteria. To examine feasibility and effectiveness, manuscripts were reviewed in parallel with traditional journal review. A total of 162 reviews were completed, and survey data from 86 participants were analyzed. The results showed that reviewers effectively evaluated Quality and Impact as separate dimensions, with Quality scores being more consistent across reviewers than Impact scores. Participants strongly supported the core elements of the Discovery Stack model and expressed enthusiasm for its broader adoption to enhance transparency, efficiency, and value in peer review. Future studies will explore integrating this model into a digital platform for reviewing and curating scientific discoveries to improve the production and dissemination of high-quality research.
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S19 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 are induced during 4T1 and MDA-MB-231 metastasis in mice
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S19 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 are induced during 4T1 and MDA-MB-231 metastasis in mice
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S16 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 surface protein after paclitaxel treatment in a subset of breast cancer cell lines
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S16 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 surface protein after paclitaxel treatment in a subset of breast cancer cell lines
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of mammary epithelial cells in reduction mammoplasty samples from the Pal and colleagues and Kumar and colleagues scRNA-seq datasets
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of mammary epithelial cells in reduction mammoplasty samples from the Pal and colleagues and Kumar and colleagues scRNA-seq datasets
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S15 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Continued experimental validation of neoplastic immune mimicry in breast cancer cell lines
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S15 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Continued experimental validation of neoplastic immune mimicry in breast cancer cell lines
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S20 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended data for MDA-MB-231 CD69 CRISPR-activation experiments and the disruption of CD69 using CRISPR/Cas9
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S20 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended data for MDA-MB-231 CD69 CRISPR-activation experiments and the disruption of CD69 using CRISPR/Cas9
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended scRNA-seq analysis of mimicked cell states in the Pal and colleagues human breast tumor scRNA-seq dataset
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended scRNA-seq analysis of mimicked cell states in the Pal and colleagues human breast tumor scRNA-seq dataset
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of the neoplastic compartment in the PANNTHR human breast tumor scRNA-seq dataset
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of the neoplastic compartment in the PANNTHR human breast tumor scRNA-seq dataset